The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Glucose Metabolism in Patients With Schizophrenia Treated With Atypical Antipsychotic Agents: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis
Abstract
BACKGROUND: While the incidence of new-onset diabetes mellitus may be increasing in patients with schizophrenia treated with certain atypical antipsychotic agents, it remains unclear whether atypical agents are directly affecting glucose metabolism or simply increasing known risk factors for diabetes. OBJECTIVE: To study the 2 drugs most clearly implicated (clozapine and olanzapine) and risperidone using a frequently sampled intravenous glucose tolerance test. DESIGN: A cross-sectional design in stable, treated patients with schizophrenia evaluated using a frequently sampled intravenous glucose tolerance test and the Bergman minimal model analysis. SETTING: Subjects were recruited from an urban community mental health clinic and were studied at a general clinical research center. Patients Fifty subjects signed informed consent and 41 underwent the frequently sampled intravenous glucose tolerance test. Thirty-six nonobese subjects with schizophrenia or schizoaffective disorder, matched by body mass index and treated with either clozapine, olanzapine, or risperidone, were included in the analysis. MAIN OUTCOME MEASURES: Fasting plasma glucose and fasting serum insulin levels, insulin sensitivity index, homeostasis model assessment of insulin resistance, and glucose effectiveness. RESULTS: The mean +/- SD duration of treatment with the identified atypical antipsychotic agent was 68.3 +/- 28.9 months (clozapine), 29.5 +/- 17.5 months (olanzapine), and 40.9 +/- 33.7 (risperidone). Fasting serum insulin concentrations differed among groups (F(33) = 3.35; P = .047) (clozapine>olanzapine>risperidone) with significant differences between clozapine and risperidone (t(33) = 2.32; P = .03) and olanzapine and risperidone (t(33) = 2.15; P = .04). There was a significant difference in insulin sensitivity index among groups (F(33) = 10.66; P<.001) (clozapine olanzapine>risperidone) (clozapine vs risperidone, t(33) = 2.94; P = .006; olanzapine vs risperidone, t(33) = 2.42; P = .02). There was a significant difference among groups in glucose effectiveness (F(30) = 4.18; P = .02) (clozapine<olanzapine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Durnin, J. V. G. A., & Womersley, J. (1974) · British Journal of Nutrition · doi:10.1079/bjn19740060 · Cited by 6,343
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Self-citationWarnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,159
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 2×
“Family history of diabetes mellitus, No. (%) of patients .89 Yes 5 (42) 4 ( 33 ) 4 (33)”
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Pi-Sunyer, F. X. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00006 · Cited by 1,371
Validation of tetrapolar bioelectrical impedance method to assess human body composition
Lukaski, H. C., Bolonchuk, W. W., Hall, C. B., & Siders, W. A. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.4.1327 · Cited by 1,370
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
A collection of Physical Activity Questionnaires for health-related research.
Pereira, M. A., FitzerGerald, S. J., Gregg, E. W., JOSWIAK, M. L., Ryan, W. J., Suminski, R. R., Utter, A. C., & Zmuda, J. M. (1997) · PubMed · Cited by 1,051
Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach
Bergman, R. N. (1989) · Diabetes · doi:10.2337/diab.38.12.1512 · Cited by 1,001
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Pi-Sunyer, F. X. (2002) · Obesity Surgery · doi:10.1007/bf03342140 · Cited by 827
Bergman, R. N., Prager, R., Volund, A., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112886 · Cited by 772
Sources of data for developing and maintaining a nutrient database
Schakel, S. F., Sievert, Y. A., & Buzzard, I. M. (1988) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)07997-9 · Cited by 745
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Self-citationBioelectrical Impedance Analysis: A Review of Principles and Applications
Kushner, R. F. (1992) · Journal of the American College of Nutrition · doi:10.1080/07315724.1992.12098245 · Cited by 625
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Sernyak, M. J., Leslie, D. L., Alarcon, R. D., Losonczy, M. F., & Rosenheck, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.561 · Cited by 623
Goodpaster, B. H., Krishnaswami, S., Resnick, H., Kelley, D. E., Haggerty, C., Harris, T. B., Schwartz, A. V., Kritchevsky, S., & Newman, A. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.372 · Cited by 619
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 595
Self-citationAutomated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
McNamara, J. R., & Schaefer, E. J. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90188-4 · Cited by 521
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Newcomer, J. W., Haupt, D. W., Fucetola, R., Melson, A. K., Schweiger, J. A., Cooper, B. P., & Selke, G. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.337 · Cited by 520
Koro, C. E., Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L., Kreyenbuhl, J., Revicki, D., & Buchanan, R. (2002) · BMJ · doi:10.1136/bmj.325.7358.243 · Cited by 421
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
Diabetes mellitus in schizophrenic patients
Mukherjee, S., Decina, P., Bocola, V., Saraceni, F., & Scapicchio, P. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90054-1 · Cited by 368
Olanzapine‐Associated Diabetes Mellitus
Koller, E. A., & Doraiswamy, P. M. (2002) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.11.841.33629 · Cited by 303
Melkersson, K. I., Hulting, A.-L., & Brismar, K. E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1006 · Cited by 299
Role of Glucose Effectiveness in the Determination of Glucose Tolerance
Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C., & Bergman, R. N. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.1018 · Cited by 290
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
Hermans, M. P., Levy, J. C., Morris, R. J., & Turner, R. C. (1999) · Diabetologia · doi:10.1007/s001250051215 · Cited by 260
Koller, E., Schneider, B., Bennett, K., & Dubitsky, G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01000-2 · Cited by 250
Gianfrancesco, F. D., Grogg, A. L., Mahmoud, R. A., Wang, R.-H., & Nasrallah, H. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1010 · Cited by 237
Lund, B. C., Perry, P. J., Brooks, J. M., & Arndt, S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1172 · Cited by 194
Haffner, S. M., Howard, G., Mayer, E., Bergman, R. N., Savage, P. J., Rewers, M., Mykkänen, L., Karter, A. J., Hamman, R., & Saad, M. F. (1997) · Diabetes · doi:10.2337/diab.46.1.63 · Cited by 194
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States
Buse, J. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00588-7 · Cited by 176
Atypical Antipsychotic???Induced Diabetes Mellitus: How Strong is the Evidence?
Henderson, D. C. (2002) · CNS Drugs · doi:10.2165/00023210-200216020-00001 · Cited by 162
Self-citationRisperidone‐Associated Diabetes Mellitus: A Pharmacovigilance Study
Koller, E. A., Cross, J. T., Doraiswamy, P. M., & Schneider, B. S. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.735.32178 · Cited by 160
Intravenous Glucose Tolerance Test-Derived Insulin Sensitivity Changes during the Menstrual Cycle*
Valdés, C. T., & Elkind-Hirsch, K. E. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-3-642 · Cited by 146
Atypical antipsychotics and hyperglycaemia
Mir, S. A., & Taylor, D. M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200103000-00001 · Cited by 132
The Risk of Diabetes During Olanzapine Use Compared With Risperidone Use
Jaime, J., Ward, A., Levinton, C. M., & Robinson, K. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1208 · Cited by 131
Sowell, M. O., Mukhopadhyay, N. D., Cavazzoni, P. A., Shankar, S. S., Steinberg, H. O., Breier, A. F., Beasley, C. M., & Dananberg, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8599 · Cited by 129
Melkersson, K. I., Hulting, A., & Brismar, K. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1112 · Cited by 125
Macor, C., Ruggeri, A., Mazzonetto, P., Federspil, G., Cobelli, C., & Vettor, R. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90288-2 · Cited by 110
Kornegay, C. J., Vasilakis‐Scaramozza, C., & Jick, H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0902 · Cited by 98
Clozapine Use and Risk of Diabetes Mellitus
Wang, P. S., Glynn, R. J., Ganz, D. A., Schneeweiß, S., Levin, R., & Avorn, J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00002 · Cited by 90
Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells
Dwyer, D. S., Pinkofsky, H. B., Liu, Y., & Bradley, R. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00092-x · Cited by 83
Hägg, S., Söderberg, S., Åhrén, B., et al. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1102 · Cited by 80
CHRISTIE, J. E., Whalley, L. J., Dick, H., Blackwood, D. M. R., Blackburn, I. M., & Fink, G. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.1.58 · Cited by 75
Effects of long-term treatment with antipsychotics on serum leptin levels
Herrán, A., García‐Unzueta, M. T., Amado, J., Maza, M. T. D. L., Álvarez, C. F., & Vázquez‐Barquero, J. L. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.1.59 · Cited by 70
Haffner, S. M., D’Agostino, R., Festa, A., Bergman, R. N., Mykkänen, L., Karter, A. J., Saad, M. F., & Wagenknecht, L. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2796 · Cited by 61
Watanabe, R. M., Azen, C., Roy, S., Perlman, J. A., & Bergman, R. N. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962320 · Cited by 55
Disturbed Endocrine Function in the Psychoses
Whalley, L. J., CHRISTIE, J. E., Blackwood, D., Bennie, J., Dick, H., Blackburn, I. M., & Fink, G. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.155.4.455 · Cited by 50
Toward an Integrated Phenotype in Pre‐NIDDM
Bergman, R. N., Watanabe, R. M., Rebrin, K., Ader, M., & Steil, G. (1996) · Diabetic Medicine · doi:10.1002/dme.1996.13.s6.67 · Cited by 43
Wik, G. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1440425 · Cited by 41
Henderson, D. C. (2001) · PubMed · Cited by 34
Self-citationDiabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents
Henderson, D. C. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0072-8 · Cited by 18
Self-citation
Cited by
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 714
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Metadata
- Authors
- Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P., Evins, A. E., Hayden, D., Weber, M. T., Anderson, E. J., Allison, D. B., Daley, T. B., Schoenfeld, D., & Goff, D. C.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2005-01-01
- Volume
- 62
- Issue
- 1
- Pages
- 19
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2053550022
- Cited by
- 319
- References
- 59
- FWCI
- 21.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.